Human CXCL16 Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB976
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Mouse
Applications
Validated:
CyTOF-ready, Flow Cytometry, Neutralization, Western Blot
Cited:
Neutralization
Label
Unconjugated
Antibody Source
Monoclonal Rat IgG2A Clone # 256213
Product Specifications
Immunogen
E. coli-derived recombinant human CXCL16
Asn30-Pro118
Accession # Q9H2A7.4
Asn30-Pro118
Accession # Q9H2A7.4
Specificity
Detects human CXCL16 in direct ELISAs and Western blots. In Western blots, no cross-reactivity with recombinant human CXCL1, 2, 3, 5, 6, 7, 8, 9, 10, 11, 12/SDF-1 alpha,12/SDF-1 beta, 13, recombinant mouse CXCL1, 2, 6, 9, 10, 12/SDF-1 alpha, 13, 16, recombinant rat CXCL1, 2, 3/CINC-2 alpha, 3/CINC-2 beta, recombinant canine CXCL8, or recombinant porcine CXCL8 is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Scientific Data Images for Human CXCL16 Antibody
Chemotaxis Induced by CXCL16 and Neutralization by Human CXCL16 Antibody.
Recombinant Human CXCL16 Chemokine Domain (Catalog # 976-CX) chemoattracts the BaF3 mouse pro-B cell line transfected with mouse CXCR6 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Human CXCL16 Chemokine Domain (20 ng/mL) is neutralized (green line) by increasing concentrations of Human CXCL16 Monoclonal Antibody (Catalog # MAB976). The ND50 is typically 2-8 µg/mL.Applications for Human CXCL16 Antibody
Application
Recommended Usage
CyTOF-ready
Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
Flow Cytometry
2.5 µg/106 cells
Sample: Human monocyte-derived dendritic cells
Sample: Human monocyte-derived dendritic cells
Western Blot
1 µg/mL
Sample: Recombinant Human CXCL16 Chemokine Domain (Catalog # 976-CX) under non-reducing conditions only
Sample: Recombinant Human CXCL16 Chemokine Domain (Catalog # 976-CX) under non-reducing conditions only
Neutralization
Measured by its ability to neutralize CXCL16-induced chemotaxis in the BaF3 mouse pro-B cell line transfected with mouse CXCR6. Matloubian, M. et al. (2000) Nature Immunol. 1:298. The Neutralization Dose (ND50) is typically 2-8 µg/mL in the presence of 20 ng/mL Recombinant Human CXCL16 Chemokine Domain.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CXCL16
CXCL16 is a transmembrane protein with an extracellular domain consisting of a chemokine domain suspended on a mucin-like stalk. It functions as a ligand for the HIV co‑receptor, CXCR6 (Bonzo).
Alternate Names
CXCL16
Gene Symbol
CXCL16
UniProt
Additional CXCL16 Products
Product Documents for Human CXCL16 Antibody
Product Specific Notices for Human CXCL16 Antibody
For research use only
Loading...
Loading...
Loading...
Loading...
Loading...